| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―May―16 |
1,25-Dihydroxyvitamin D3 attenuates platelet aggregation potentiated by SARS-CoV-2 spike protein via inhibiting integrin αIIbβ3 outside-in signaling |
Ruijie Wang, Zezhong Tian, Caixia Wang, Bingying Zhang, Meiyan Zhu, Yan Yang |
| 2 |
[GO] |
2023―Nov―10 |
COVID-19-associated liver injury: Adding fuel to the flame |
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, et al. (+2) Zili Zhang, Shizhong Zheng |
| 3 |
[GO] |
2023―May―03 |
Laboratory methods: A concise review and update for COVID-19 diagnosis |
Mohadeseh Nemati, Ameneh Jafari, Yaser Ebrahimi, Ali Golchin, Fahima Danesh Pouya, Mostafa Rezaei-Tavirani, Yousef Rasmi |
| 4 |
[GO] |
2023―Mar―17 |
Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2 |
Pedro José Tronco Pauletto, Cassia Pereira Delgado, João Batista Teixeira da Rocha |
| 5 |
[GO] |
2022―Dec―15 |
Molecular modeling of C1-inhibitor as SARS-CoV-2 target identified from the immune signatures of multiple tissues: An integrated bioinformatics study |
Karthik Sekaran, Rinku Polachirakkal Varghese, R. Gnanasambandan, G. Karthik, I. Ramya, C. George Priya Doss |
| 6 |
[GO] |
2022―Dec―07 |
Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: Docking and molecular dynamics studies to elucidate viral action |
Saroj Kumar Panda, Parth Sarthi Sen Gupta, Malay Kumar Rana |
| 7 |
[GO] |
2022―Oct―07 |
Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight |
Rahul Singh, Vijay K. Bhardwaj, Rituraj Purohit |
| 8 |
[GO] |
2022―Aug―18 |
Systemic redox imbalance in severe COVID-19 patients |
Isabelle A. L. Postiga, Paula C. Teixeira, Carla Andretta Moreira Neves, Paulo Santana Filho, Bruna Marmett, Roseana Carvalho, et al. (+5) Alessandra Peres, Liane Rotta, Claudia Elizabeth Thompson, Gilson P. Dorneles, Pedro R. T. Romão |
| 9 |
[GO] |
2022―Jul―14 |
NK cell dysfunction is linked with disease severity in SARS-CoV-2 patients |
Khadijeh Dizaji Asl, Zeinab Mazloumi, Ghazal Majidi, Hossein Kalarestaghi, Shahnaz Sabetkam, Ali Rafat |
| 10 |
[GO] |
2022―Jun―01 |
Application of exosomes for the alleviation of COVID-19-related pathologies |
Aysa Rezabakhsh, Mahdi Mahdipour, Alireza Nourazarian, Paria Habibollahi, Emel Sokullu, Çigir Biray Avci, Reza Rahbarghazi |
| 11 |
[GO] |
2020―Dec―15 |
Nano-based methods for novel coronavirus 2019 (
2019-nCoV
) diagnosis: A review |
Vahid Rahimkhoei, Jafar Rezaie, Ali Akbari, Aynaz Nourani, Nassrollah Jabbari, Zohreh Mehri Lighvan, Mojtaba Amini |
| 12 |
[GO] |
2020―Nov―03 |
Is there a link between vitamin D status,
SARS-CoV
-2 infection risk and
COVID
-19 severity? |
Davide Ferrari, Massimo Locatelli, Matteo Briguglio, Giovanni Lombardi |
| 13 |
[GO] |
2020―Sep―29 |
SARS-COV
-2 (
COVID
-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments |
Hakan Parlakpinar, Mehmet Gunata |
| 14 |
[GO] |
2020―Aug―28 |
Potential small-molecule drugs as available weapons to fight novel coronavirus (
2019-nCoV
): A review |
Vahid Rahimkhoei, Nassrollah Jabbari, Aynaz Nourani, Sina Sharifi, Ali Akbari |
